Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Health Promotion and Cardiovascular Prevention, Acute Myocardial Infarction Research, and Blood Pressure and Hypertension Studies.
Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk
Prognostic Value of Cardiovascular Biomarkers in the Population
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
Drinking alcohol in moderation is associated with lower rate of all-cause mortality in individuals with higher rather than lower educational level: findings from the MORGAM project
Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study
Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women
Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium
Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women The MORGAM Project
University of Southern Denmark Research Portal (University of Southern Denmark) 2021cited by 2position: middle
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
Alcohol Intake and Total Mortality in 142,960 Individuals from the MORGAM Project: a population‐based study
Research Portal (Queen's University Belfast) 2021cited by 0position: middle
Association of glycated haemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE consortium
Repositioning of the global epicentre of non-optimal cholesterol
Does Estimated Pulse Wave Velocity Add Prognostic Information?
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Non-linear (J-shaped) association of alcohol intake with total mortality: Results from the MORGAM project
Abstract P227: Association of Alcohol Intake with Cardiovascular and Total Mortality
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci
Exome-wide association study of plasma lipids in >300,000 individuals
Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium
Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
A genomic approach to therapeutic target validation identifies a glucose-lowering <i>GLP1R</i> variant protective for coronary heart disease